Neelakantan 2018 diet-induced obesity study
If it does not work for you personally, you have a documented path to a refund on the product cost.* You are probably not the right fit if you are expecting guaranteed clinical outcomes on a defined timeline, are not prepared to consult a healthcare provider about adding a research-stage peptide compound, or are looking for the cheapest possible way to access BPC-157 regardless of manufacturing quality or purchasing protections
First isolated and characterized in 1993 by researchers at the University of Zagreb, Croatia, this peptide was derived from a larger protein naturally found in human gastric juice
In Phase 2 research, this pharmacological profile translated into the largest average weight reductions ever reported for a once-weekly peptide, catalyzing widespread interest among endocrinologists, obesity researchers, and metabolic-disease scientists
"Stable gastric pentadecapeptide BPC-157: Novel therapy in gastrointestinal tract and other organ systems." Curr Pharm Des